ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980

Bourne Tells ACCC White House Backs Hospice Concept

May 12, 1978

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981

Pressure Builds On President To Sign Authorization Bill; No Movement Yet On Appropriations Measure

November 8, 1985